References
- Gl Bell, Sanchcz-Pescador R, Laybourn P J, Najarian RC. Exon duplication and divergence in the human preproglucagon gene. Nature 1983; 304: 368–71
- Buhr T, Thim L, Kofod H, ørskov C, Harling H, Hoist JJ. Naturally occurring products of pro-glucagon 111 -160 in the porcine and human small intestine. J Biol Chem 1988; 263: 8621–4
- Hoist J J, ørskov C, Nielsen O V, Schwartz TW. Truncated glucagon-likc peptidel, an insulin-releasing hormone from the distal gut. FEBS Lett 1987; 221: 169–74
- Kreymann B, Williams G, Ghatei M A, Bloom SR. Glucagon-like peptide-1 7–36: A physiological incrctin in man. Lancet 1987; 2: 1300–3
- Manaka H, Taniguchi H, Wada K, Takahashi H, Takahashi K, Katagiri T, Sasaki H. Glucagon-likc peptide-1 in the rat pancreas. Biomedical Res 1987; 8: 1–8
- Mojsov S, Weir G C, Habener JF. Insulino-tropin: Glucagon-like peptide-1 (7–37) co-encoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas. J Clin Invest 1987; 79: 616–9
- Vailiant C R, Lund PK. Distribution of glucagon-like peptide-1 in the canine and feline pancreas and gastrointestinal tract. J Histochem Cytochem 1986; 9: 1117–21
- Kawai K, Suzuki S, Ohashi H, Murayama Y, Yamashita K. Comparison of the effects of glucagon-like peptide-1 (1–37) and -(7–37) and glucagon on islets hormone release from isolated perfused canine and rat pancreas. Endocrinology 1989; 124: 1768–73
- Shima K, Hirota M, Ohboshi C. Effect of glucagon-like peptide-1 on insulin secretion. Regul Peptides 1988; 22: 245–52
- Creutzfeldt W, Ebert R. New developments in the incretin concept. Diabetologia 1985; 28: 565–73
- Stöckmann F, Ebert R, Creutzfeldt W. Preceding hyperinsulinemia prevents demonstration of insulin effect on fat induced gastric inhibitory polypeptide (GIP). Diabetes 1984; 33: 580–5
- Takahashi H, Manaka H, Suda K, Fukase N, Takahashi K, Tominaga M, Sasaki H. Determination of GLP-1 in human plasma using N-terminal and C-terminal antibodies. Biomedical Res 1988; 1: 90, Suppl.
- Nishino T, Kodaira T, Shin S, Imagawa K, Shima K, Kumahara Y, Yanaihara C, Yanaihara N. Glucagon radioimmunoasay with use of antiserum to glucagon C-terminal fragment. Clin Chem 1981; 27: 1690–7
- Harris V, Faloona G R, Linger RH. Glucagon. Methods of hormone radioimmunoassay, BM Jaffe, HR Behrman. Academic Press, New York 1979; 643–56
- Krarup T, Hoist JJ. The heterogeneity of gastric inhibitory polypeptide in porcine and human gastrointestinal mucosa evaluated with five different antisera. Regul Peptides 1984; 9: 35–46
- Takahashi H, Manaka H, Suda K, Fukase N, Tominaga M, Sasaki H, Kawai K, Ohashi S. Radioimmunoassay for glucagon-like peptide-1 in human plasma using N-terminal and C-terminal directed antibodies: A physiologic insulinotropic role of GLP-1 (7–36 amide). Biomedical Res 1990; 11(2)99–108
- Unger R H, Eisentraut AH. Entero-insular axis. Arch Intern Med 1969; 123: 261–6
- Zunz E, LaBarre J. Contributions à ľétude des variations physiologiques de la sécrétion interne du pancreas: relations entre les sécretions externe et interne du pancréas. Arch Int Physiol Biochim 1929; 31: 20–44
- Creutzfeldt W. The incretin concept today. Diabetologia 1979; 16: 75–85
- MacGregor I L, Gueller R, Watts H D, Meyer JH. The effect of acute hyperglycemia on gastric emptying in man. Gastroenterology 1976; 70: 190–6
- Ebert R, Frcrichs H, Creutzfeldt W. Impaired feed back control of fat induced gastric inhibitory polypeptide (GIP) secretion by insulin in obesity and glucose intolerance. Eur J Clin Invest 1979; 9: 129–35
- Takahashi H, Manaka H, Fukase N, Sugiyama K, Igarashi M, Sasaki H, Sato M, Harada M. The response of plasma glucagon-like peptide (GLP-1) after oral glucose loading in patients with gastrectomy. Yamagata Med J 1991; 1: 43–50